RxDoctor Payments Data

Tyler Ptacek, MD

Interventional Pain Medicine · Rapid City, SDNPI 1225324791

Payments from drug & device makers

$124,614in general payments, 2019–2025

Across 505 payments — averaging $246.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genesys Orthopedics Systems, L.L.C.$70K
  • Nevro Corp.$23K
  • Relievant Medsystems, Inc.$10K
  • Medtronic$6K
  • Abbott$5K
  • Vertos Medical, Inc.$2K
  • plus $9K from 23 others
$2,015in research payments, 2019–2025

Across 4 payments — averaging $503.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genesys Orthopedics Systems, L.L.C.$2K

What the payments were for

  • Consulting fees$66,06053%
  • Speaking & faculty fees$7,2106%
  • Travel & lodging$29,58024%
  • Food & beverage$17,98414%
  • Education$1010%
  • Gifts$3,6793%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few interventional pain medicine providers in South Dakotato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$646,754
Medicare patients
567
Services billed
23,853

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl12$10,465
Buprenorphine32$9,564
MovantikNaloxegol Oxalate17$6,685
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen201$2,775
Gabapentin154$1,890
Pregabalin73$1,609
Baclofen93$1,196
Morphine Sulfate24$813
Tizanidine Hcl108$700
Tramadol Hcl85$588
Duloxetine Hcl41$534
Topiramate34$426
Cyclobenzaprine Hcl46$315
Hydromorphone Hcl19$286
Acetaminophen-CodeineAcetaminophen With Codeine14$268

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Rapid City

Where these figures come from

Is this you, or does something look wrong? →